These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8715552)

  • 41. Characteristics and symptom management of progressive supranuclear palsy: a multidisciplinary approach.
    Ward C
    J Neurosci Nurs; 2006 Aug; 38(4):242-7. PubMed ID: 16925000
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ["Pure akinesia" and progressive supranuclear palsy].
    Mizusawa H
    No To Shinkei; 1993 Feb; 45(2):113-8. PubMed ID: 8476660
    [No Abstract]   [Full Text] [Related]  

  • 43. [Progressive supranuclear palsy: living environment of the patients in Germany].
    Hensler M; Paul S; Abright C; Lorenzl S
    Nervenarzt; 2011 Feb; 82(2):207-14. PubMed ID: 20669002
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repetitive finger movement performance differs among Parkinson's disease, Progressive Supranuclear Palsy, and spinocerebellar ataxia.
    Stegemöller EL; Uzochukwu J; Tillman MD; McFarland NR; Subramony SH; Okun MS; Hass CJ
    J Clin Mov Disord; 2015; 2():6. PubMed ID: 26788342
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dantrolene for muscle rigidity in progressive supranuclear palsy.
    Khan N
    BMJ Support Palliat Care; 2023 Dec; 13(e2):e306-e307. PubMed ID: 33952581
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [An autopsy case of progressive supranuclear palsy (author's transl)].
    Eto M; Izumi K; Jyôhuku N; Akagi G
    Rinsho Shinkeigaku; 1980 Sep; 20(9):691-6. PubMed ID: 7460430
    [No Abstract]   [Full Text] [Related]  

  • 47. Arm levitation and utilisation behaviour in a patient with progressive supranuclear palsy.
    Divjak T; Kojovic M
    Cortex; 2020 Feb; 123():203-205. PubMed ID: 31926594
    [No Abstract]   [Full Text] [Related]  

  • 48. Progressive supranuclear palsy.
    Burn DJ; Lees AJ
    Handb Clin Neurol; 2007; 84():327-49. PubMed ID: 18808956
    [No Abstract]   [Full Text] [Related]  

  • 49. Four-Repeat Tauopathies: Current Management and Future Treatments.
    VandeVrede L; Ljubenkov PA; Rojas JC; Welch AE; Boxer AL
    Neurotherapeutics; 2020 Oct; 17(4):1563-1581. PubMed ID: 32676851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Progressive supranuclear palsy: neurological, neuropathological and neuropsychological aspects].
    Gómez-Haro C; Espert-Tortajada R; Gadea-Doménech M; Navarro-Humanes JF
    Rev Neurol; 1999 Nov 16-30; 29(10):936-56. PubMed ID: 10637844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progressive supranuclear palsy.
    Pourfar M; Vonsattel JP
    Sci Aging Knowledge Environ; 2004 Jul; 2004(30):dn1. PubMed ID: 15282366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. "Learned helplessness" and the patient with progressive supranuclear palsy.
    Kube M; Wernick M; Murphy S
    Adv Clin Care; 1990; 5(3):24-7. PubMed ID: 2328072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural history and clinical features of progressive supranuclear palsy: a clinical study.
    Diroma C; Dell'Aquila C; Fraddosio A; Lamberti S; Mastronardi R; Russo I; De Mari M; Iliceto G
    Neurol Sci; 2003 Oct; 24(3):176-7. PubMed ID: 14598074
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [A 65-year-old man with rigid-bradykinetic parkinsonism, vertical gaze palsy, difficulty of eye-lid opening, and marked pseudo-bulbar palsy].
    Noda K; Kobayashi T; Matsuoka S; Takanashi M; Kanazawa A; Mizuno Y
    No To Shinkei; 2005 Jan; 57(1):73-86. PubMed ID: 15782604
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Progressive supranuclear palsy: managing the disabilities and providing nursing support.
    Rohs G
    Axone; 1996 Mar; 17(3):60-5. PubMed ID: 8715552
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.